It depends on which of three kinds you have: FDA-approved, compounded or "research use only". An approved peptide has passed clinical trials and its side effects are known, while a research-use vial has no regulatory oversight at all.
"Are peptides safe" is the wrong question
Safety depends entirely on which peptide, how it was manufactured, and how it is used. Three categories do most of the work.
Tier 1: FDA-approved peptides
Pharmaceutical peptides that have passed rigorous clinical trials: insulin for diabetes, semaglutide for weight loss, tesamorelin for visceral fat. These are well characterised, with known side effect profiles, manufactured to strict pharmaceutical standards, and prescribed under medical supervision.
You still get side effects. You still get contraindications. But you know what they are, because thousands of people were studied before the drug reached you.
Tier 2: Compounded peptides
Many wellness and anti-aging clinics have prescribed custom-compounded peptides, among them BPC-157, TB-500 and CJC-1295, through licensed compounding pharmacies.
The regulatory picture here has moved three times in 2026, and almost every summary of it circulating online is wrong. The FDA categorised several popular peptides as "Category 2" substances, bulk drug substances that may present significant safety risks. In April 2026 twelve of them came off that list, and in July 2026 an advisory committee voted to recommend four for the compounding list.
Neither of those things made anything legal to compound. The next lesson unpacks why, because it is the single most common misconception a reader arrives with, and getting it wrong changes what you believe you are buying.
Injectable GHK-Cu is the useful counterexample, and not in the direction most people assume: it came off Category 2 in April 2026 because the nominator withdrew, while topical GHK-Cu was removed from Category 1 on the same day and lost the enforcement discretion it previously had. The same compound moved in opposite directions, and the route with the human evidence behind it ended up worse off.
Tier 3: "Research use only" peptides
Peptides bought online labelled "research chemicals" or "not for human consumption" bypass regulatory oversight entirely. Independent testing has found:
- Purity problems: some products testing as low as 60% against a claimed 98%+
- Incorrect dosing: under-dosed or over-dosed relative to the label
- Contaminants: bacterial endotoxins, heavy metals, unknown compounds
- Wrong substance entirely: a different chemical than the label states
That last one is the reason mass spectrometry matters on a certificate of analysis. Without identity confirmation, a vial labelled BPC-157 could contain something else completely, and you would have no way to know.
The practical conclusion
Sourcing from tested suppliers is not a nice-to-have at Tier 3. It is the only thing standing between you and an unknown compound.
The minimum standard is batch-specific, third-party certificates of analysis showing HPLC purity ≥98% and mass spectrometry identity confirmation. Module 2 covers exactly how to read one.
What to do before your first dose
The Playbook lists four things, and skipping them is the most common mistake:
- 1.Get baseline bloodwork. IGF-1, complete metabolic panel, complete blood count, lipid panel. You need a "before" picture to evaluate the "after".
- 2.Tell your healthcare provider. Drug interactions with peptides are understudied. If you take anything, especially blood pressure medication, diabetes medication, CNS depressants or immunosuppressants, your doctor needs the full picture.
- 3.Verify your source. A contaminated peptide is worse than no peptide.
- 4.Check for contraindications. Active or recent cancer or family cancer history, pregnancy or nursing, under 25, and immunosuppressants or transplant status all require a conversation with a provider first.
None of that is ceremony. Each item exists because someone skipped it and it mattered.